What is the recommended antibiotic regimen for spontaneous bacterial peritonitis and secondary bacterial peritonitis?

Antibiotic Regimen for Bacterial Peritonitis

For spontaneous bacterial peritonitis (SBP), initiate empirical treatment with a third-generation cephalosporin (cefotaxime 2g IV every 8 hours for 5 days) for community-acquired infection, or a carbapenem/piperacillin-tazobactam for healthcare-associated/nosocomial infection, plus IV albumin (1.5 g/kg on day 1 and 1 g/kg on day 3). 1, 2

Spontaneous Bacterial Peritonitis (SBP)

Initial Empirical Treatment

The antibiotic choice depends critically on the setting of infection acquisition:

Community-Acquired SBP:

• Cefotaxime 2g IV every 8 hours is the gold standard, extensively studied and remains first-line 1, 2, 3
• Alternative: Levofloxacin (acceptable for patients not on fluoroquinolone prophylaxis or with penicillin allergy) 4
• Treatment duration: 5 days 5

Healthcare-Associated or Nosocomial SBP:

• Piperacillin-tazobactam or carbapenem should be used empirically 1, 3
• This is critical because gram-positive cocci (Staphylococcus, Enterococcus) and multidrug-resistant organisms have become increasingly common in these settings 4
• Local resistance patterns should guide final selection 2

Essential Adjunctive Therapy

IV albumin is mandatory and improves mortality by preventing renal dysfunction:

• Day 1: 1.5 g/kg
• Day 3: 1.0 g/kg
• Patients with acute kidney injury or jaundice at diagnosis benefit most 1

Monitoring Response

• Repeat paracentesis at 48 hours if inadequate clinical response or if secondary peritonitis is suspected 1, 2
• A decrease in ascitic fluid PMN count <25% from baseline indicates treatment failure and requires broadening antibiotic coverage 1

Critical Pitfall: Antibiotic Resistance

Patients on fluoroquinolone prophylaxis have significantly higher resistance rates (34% fluoroquinolone resistance vs 14% without prophylaxis) 6. This makes empirical fluoroquinolone therapy inappropriate in these patients—use cefotaxime or broader coverage instead.

Secondary Bacterial Peritonitis

Secondary peritonitis requires broader antimicrobial coverage with anti-anaerobic activity plus urgent surgical intervention. 7

Antibiotic Regimen

• Third-generation cephalosporin PLUS metronidazole is the standard approach 8
• Alternative: Piperacillin-tazobactam or carbapenem (provides both gram-negative and anaerobic coverage)
• These regimens must cover polymicrobial flora including anaerobes, which are absent in SBP 7

Key Distinguishing Features

Secondary peritonitis has:

• Higher mortality (60-80%) compared to SBP 7
• Multiple organisms on culture (vs. single organism in SBP)
• Evidence of hollow organ perforation or intra-abdominal inflammatory process
• Requires immediate surgical source control in addition to antibiotics 7
• Higher CRP and sedimentation rates compared to SBP 9

Diagnostic Approach

When ascitic fluid analysis suggests secondary peritonitis (multiple organisms, very high protein, elevated LDH), perform abdominal CT immediately to identify the surgical source 7. Do not delay surgical consultation.

Prophylaxis Considerations (Context for Treatment Decisions)

Understanding prophylaxis patterns helps predict resistance:

Secondary Prophylaxis (after first SBP episode):

• Norfloxacin 400mg daily (withdrawn from US market in 2014) 1
• Ciprofloxacin 500mg daily is the reasonable alternative 1, 2
• Rifaximin showed lower 6-month SBP recurrence (4% vs 14% with norfloxacin) 1
• Important caveat: Prophylaxis is associated with higher rates of non-SBP infections (UTIs, pneumonia, bacteremia) and increased antibiotic resistance 10, 6

Primary Prophylaxis:

• Reserved for high-risk patients: ascitic protein <1.5 g/dL with advanced liver failure (Child-Pugh >9 with bilirubin >3 mg/dL) or renal dysfunction 1
• Ceftriaxone IV is recommended for patients with GI hemorrhage until bleeding resolves 1, 2

Algorithm Summary

1. Determine infection type: SBP (single organism, no surgical source) vs. secondary peritonitis (multiple organisms, surgical pathology)

2. For SBP, assess acquisition setting:

   • Community-acquired → Cefotaxime 2g IV q8h
   • Healthcare-associated/nosocomial → Piperacillin-tazobactam or carbapenem
   • On fluoroquinolone prophylaxis → Avoid fluoroquinolones, use cefotaxime or broader

3. Add IV albumin (1.5 g/kg day 1.0 g/kg day 3)

4. For secondary peritonitis: Third-generation cephalosporin + metronidazole (or piperacillin-tazobactam/carbapenem) + urgent surgical consultation

5. Reassess at 48 hours: Repeat paracentesis if poor response; adjust based on cultures and local susceptibility patterns